As momentum for direct-to-consumer (DTC) drug sales grows, a new survey from Model N, the leader in revenue optimization and compliance ...
Negative market sentiment sent Model N shares lower. Investors did not react well to the latest strong quarterly earnings report. Subscription revenue growth, one of several catalysts to consider.
SAN MATEO, Calif.--(BUSINESS WIRE)--Model N, Inc. (NYSE: MODN), the leader in revenue optimization and compliance, plans to announce financial results for the fourth quarter and fiscal year 2023 after ...
SAN MATEO, Calif.--(BUSINESS WIRE)--Model N, a leader in revenue optimization and compliance for pharmaceutical, medtech, and high-tech innovators, today announced the completion of its acquisition by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback